Skip to main content

Table 3 Adjusted difference, individual annual healthcare costs and production value (patients initiating biologics within and after 1 year) (Euros, 2016 prices)

From: The cost burden of Crohn’s disease and ulcerative colitis depending on biologic treatment status – a Danish register-based study

Years from biologic initiation

Outpatient visits

Hospital admissions

Primary sector

Production value

CD

UC

CD

UC

CD

UC

CD

UC

0

232

-75

-1462*

-2200*

-122*

-114*

1938

-169

1

-656

1497*

-661

-3189*

-30

-1

2963*

3459*

2

1563*

1583*

421

-872*

6

18

1314

1174

3

1592*

434

385

237

-19

7

2314

547

4

1193*

69

-596

-324

3

27

2998*

810

5

744

-253

-281

94

-22

0

3941*

441

6

569

-7

-133

22

-34

-29

5141*

-256

7

893

404

-894

429

-39

-3

2605

-129

8

1204

635

-1121

887

-31

88*

4313

-1880

9

1244

429

-795

-133

48

33

3329

172

10

2430*

-505

-1221*

649

135*

-34

4626

7436

  1. *p≤0.05